Loracarbef

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • No longer available in the U.S.

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Acute otitis media
  • Acute exacerbations of chronic bronchitis secondary bacterial infection of acute bronchitis
  • Acute maxillary sinusitis
  • Uncomplicated and complicated UTI.
  • Pharyngitis/tonsillitis
  • Community-acquired (CAP) caused by S. pneumoniae or H. influenzae (non-β-lactamase-producing strains only)
  • Skin and skin-structure infections (impetigo)

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved